Connection
Cathy Bradley to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Cathy Bradley has written about Carcinoma, Non-Small-Cell Lung.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.918 |
|
|
|
-
Bradley CJ, Liang R, Lindrooth RC, Sabik LM, Perraillon MC. High-Cost Cancer Drug Use in Medicare Advantage and Traditional Medicare. JAMA Health Forum. 2025 Jan 03; 6(1):e244868.
Score: 0.514
-
Morgan RL, Karam SD, Bradley CJ. Ethnic Disparities in?Imaging Utilization at Diagnosis of Non-Small Cell Lung Cancer. J Natl Cancer Inst. 2020 12 14; 112(12):1204-1212.
Score: 0.388
-
Bradley CJ, Eguchi M, Perraillon MC. Factors Associated With Use of High-Cost Agents for the Treatment of Metastatic Non-Small Cell Lung Cancer. J Natl Cancer Inst. 2020 08 01; 112(8):802-809.
Score: 0.378
-
Bradley CJ, Yabroff KR, Mariotto AB, Zeruto C, Tran Q, Warren JL. Antineoplastic Treatment of Advanced-Stage Non-Small-Cell Lung Cancer: Treatment, Survival, and Spending (2000 to 2011). J Clin Oncol. 2017 Feb 10; 35(5):529-535.
Score: 0.295
-
Bradley CJ, Dahman B, Given CW. Inadequate access to surgeons: reason for disparate cancer care? Med Care. 2009 Jul; 47(7):758-64.
Score: 0.176
-
Bradley CJ, Dahman B, Given CW. Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. J Clin Oncol. 2008 Nov 01; 26(31):5067-73.
Score: 0.166